Pay-As-You-Go Effects for S. 3525, as Introduced on September 12, 2012
Cost Estimates Search
- Cost Estimate
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187,the Food and Drug Administration Safety and Innovation Act, with Further Amendments Adopted by the Senate through May 24, 2012
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187, the Food and Drug Administration Safety and Innovation Act
- Cost Estimate
Direct spending and revenues effects estimate for the bill as cleared by the Congress on December 6, 2007, and signed by the President on December 20, 2007
- Cost Estimate
Direct spending and revenues effects estimate for the bill as cleared by the Congress on December 4, 2007, and signed by the President on December 14, 2007
- Cost Estimate
Cost estimate for the bill as passed by the Senate on December 13, 2007.
- Cost Estimate
Direct spending and revenues effects estimate for the bill as cleared by the Congress on July 11, 2007, and signed by the President on July 18, 2007
- Cost Estimate
Cost estimate for the bill as introduced on May 17, 2007.
- Cost Estimate
Cost estimate for the amendment, as amended through May 24, 2007
- Cost Estimate
Letter to the Honorable Kent Conrad